Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Thomasville National Bank

Thomasville National Bank lessened its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 92.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 7,838 shares of the medical equipment provider’s stock after selling 102,815 shares during the quarter. Thomasville National Bank’s holdings in Zimmer Biomet were worth $705,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ZBH. Dodge & Cox increased its position in Zimmer Biomet by 5.1% during the 3rd quarter. Dodge & Cox now owns 23,216,173 shares of the medical equipment provider’s stock valued at $2,286,793,000 after buying an additional 1,118,710 shares in the last quarter. Capital International Investors raised its stake in Zimmer Biomet by 11.5% in the third quarter. Capital International Investors now owns 7,550,754 shares of the medical equipment provider’s stock valued at $743,749,000 after buying an additional 778,467 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in Zimmer Biomet by 1.6% in the third quarter. Ameriprise Financial Inc. now owns 3,789,200 shares of the medical equipment provider’s stock worth $373,239,000 after acquiring an additional 58,335 shares in the last quarter. Van ECK Associates Corp boosted its holdings in Zimmer Biomet by 2.4% in the third quarter. Van ECK Associates Corp now owns 3,476,906 shares of the medical equipment provider’s stock worth $342,475,000 after acquiring an additional 82,375 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Zimmer Biomet by 1.8% during the third quarter. Dimensional Fund Advisors LP now owns 2,269,122 shares of the medical equipment provider’s stock worth $223,503,000 after acquiring an additional 39,146 shares during the last quarter. Institutional investors and hedge funds own 88.89% of the company’s stock.

Insider Buying and Selling at Zimmer Biomet

In other news, SVP Lori Winkler sold 2,650 shares of the stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $94.66, for a total value of $250,849.00. Following the sale, the senior vice president owned 10,224 shares in the company, valued at $967,803.84. This represents a 20.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.28% of the stock is owned by insiders.

Zimmer Biomet Trading Up 0.6%

Shares of NYSE:ZBH opened at $94.79 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.98 and a debt-to-equity ratio of 0.55. Zimmer Biomet Holdings, Inc. has a 52-week low of $84.59 and a 52-week high of $108.29. The stock has a market cap of $18.35 billion, a price-to-earnings ratio of 26.78, a PEG ratio of 1.93 and a beta of 0.61. The business has a 50-day moving average price of $93.56 and a 200-day moving average price of $93.33.

Zimmer Biomet (NYSE:ZBH) last issued its earnings results on Tuesday, February 10th. The medical equipment provider reported $2.42 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.04. Zimmer Biomet had a return on equity of 12.93% and a net margin of 8.56%.The firm had revenue of $2.24 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same quarter in the prior year, the firm earned $2.31 earnings per share. Zimmer Biomet’s revenue for the quarter was up 10.9% on a year-over-year basis. Zimmer Biomet has set its FY 2026 guidance at 8.300-8.450 EPS. Equities analysts predict that Zimmer Biomet Holdings, Inc. will post 8.22 EPS for the current year.

Zimmer Biomet Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, March 31st. Zimmer Biomet’s dividend payout ratio is 27.12%.

Wall Street Analyst Weigh In

ZBH has been the subject of several research analyst reports. TD Cowen raised shares of Zimmer Biomet from a “hold” rating to a “buy” rating in a research report on Monday, January 26th. Wells Fargo & Company boosted their target price on shares of Zimmer Biomet from $93.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 11th. Citigroup restated a “buy” rating on shares of Zimmer Biomet in a research note on Wednesday, February 11th. Wall Street Zen raised shares of Zimmer Biomet from a “hold” rating to a “buy” rating in a report on Saturday, April 11th. Finally, Evercore upgraded shares of Zimmer Biomet from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $94.00 to $120.00 in a research note on Monday, January 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $105.95.

Zimmer Biomet Company Profile

Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.